New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Electrical detection of RNA cancer biomarkers at the single-molecule level

Electrical detection of RNA cancer biomarkers at the single-molecule level

by Thamarasee Jeewandara , Medical XpressDetection of cancer biomarkers using the STMBJ single-molecule conductance approach. (a) Liquid biopsy samples contain circulating nucleic acids that can be de
Oncology February 24,2024
Electrical detection of RNA cancer biomarkers at the single-molecule level

Electrical detection of RNA cancer biomarkers at the single-molecule level

by Thamarasee Jeewandara , Medical XpressDetection of cancer biomarkers using the STMBJ single-molecule conductance approach. (a) Liquid biopsy samples contain circulating nucleic acids that can be de
Oncology February 24,2024
Researchers circumvent radiation resistance in subtype of brain tumors

Researchers circumvent radiation resistance in subtype of brain tumors

by University of MichiganMutant IDH1 glioma invading the normal brain structures. Non-tumor astrocytes are stained using an anti-GFAP antibody and are seen in brown. Credit: Maria Castro, Ph.D.It
Oncology February 24,2024
Researchers circumvent radiation resistance in subtype of brain tumors

Researchers circumvent radiation resistance in subtype of brain tumors

by University of MichiganMutant IDH1 glioma invading the normal brain structures. Non-tumor astrocytes are stained using an anti-GFAP antibody and are seen in brown. Credit: Maria Castro, Ph.D.It
Oncology February 24,2024
New insights into liver cancer using organoids

New insights into liver cancer using organoids

by Princess Máxima Center for Pediatric OncologyA culture of mini livers. Credit: Benedetta Artegiani / Princess Máxima Center for pediatric oncologyScientists of the Princess Máxima Center for pediat
Oncology February 24,2024
New insights into liver cancer using organoids

New insights into liver cancer using organoids

by Princess Máxima Center for Pediatric OncologyA culture of mini livers. Credit: Benedetta Artegiani / Princess Máxima Center for pediatric oncologyScientists of the Princess Máxima Center for pediat
Oncology February 24,2024
In preclinical studies, team identifies potential therapy for metastatic colon cancer

In preclinical studies, team identifies potential therapy for metastatic colon cancer

by Weill Cornell Medical CollegeMultiplex immunofluorescence image of hyaluronan-rich human colorectal cancer. Highly aggressive tumoral cells (turquoise and magenta) are negative for both aPKCs
Oncology February 24,2024
In preclinical studies, team identifies potential therapy for metastatic colon cancer

In preclinical studies, team identifies potential therapy for metastatic colon cancer

by Weill Cornell Medical CollegeMultiplex immunofluorescence image of hyaluronan-rich human colorectal cancer. Highly aggressive tumoral cells (turquoise and magenta) are negative for both aPKCs
Oncology February 24,2024
Drug turns cancer gene into 'eat me' flag for immune system

Drug turns cancer gene into 'eat me' flag for immune system

by Robin Marks,University of California, San FranciscoMicroscopy of a lung tumor biopsy. Credit: Lin MaTumor cells are notoriously good at evading the human immune system; they put up physical w
Oncology February 24,2024
Drug turns cancer gene into 'eat me' flag for immune system

Drug turns cancer gene into 'eat me' flag for immune system

by Robin Marks,University of California, San FranciscoMicroscopy of a lung tumor biopsy. Credit: Lin MaTumor cells are notoriously good at evading the human immune system; they put up physical w
Oncology February 24,2024
Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine
Oncology February 24,2024
Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine
Oncology February 24,2024
Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr
Oncology February 24,2024
Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr
Oncology February 24,2024
Sticky cell fingers help keep breast tumors contained

Sticky cell fingers help keep breast tumors contained

by University of TurkuBreast cancer cells break through the basement membrane acting as a biological barrier. In the image, the finger-like projections formed by the actin of cancer cells invadin
Oncology February 24,2024
Sticky cell fingers help keep breast tumors contained

Sticky cell fingers help keep breast tumors contained

by University of TurkuBreast cancer cells break through the basement membrane acting as a biological barrier. In the image, the finger-like projections formed by the actin of cancer cells invadin
Oncology February 24,2024
Researchers uncover how breast cancer cells become resistant to therapy

Researchers uncover how breast cancer cells become resistant to therapy

by Molly Chiu,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainAbout one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders them res
Oncology February 24,2024
Researchers uncover how breast cancer cells become resistant to therapy

Researchers uncover how breast cancer cells become resistant to therapy

by Molly Chiu,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainAbout one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders them res
Oncology February 24,2024
T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t
Oncology February 24,2024
T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t
Oncology February 24,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com